GPT and metabolic dysfunction-associated steatotic liver disease: While the remaining obese subjects without NAFLD (n=290) had a high CHOL, LDL, and TGL in 25%, 6.3%, and 12.5%, respectively, and high ALT and AST in 12.5% and 6.3% of this group, respectively.